Whether human IL-10-producing regulatory T cells ("Tr1") represent a distinct differentiation lineage or an unstable activation stage remains a key unsolved issue. Here, we report that Eomesodermin (Eomes) acted as a lineage-defining transcription factor in human IFN-γ/IL-10 coproducing Tr1-like cells. In vivo occurring Tr1-like cells expressed Eomes, and were clearly distinct from all other CD4+ T-cell subsets, including conventional cytotoxic CD4+ T cells. They expressed Granzyme (Gzm) K, but had lost CD40L and IL-7R expression. Eomes antagonized the Th17 fate, and directly controlled IFN-γ and GzmK expression. However, Eomes binding to the IL-10 promoter was not detectable in human CD4+ T cells, presumably because critical Tbox binding sites of the mouse were not conserved. A precommitment to a Tr1-like fate, i.e. concominant induction of Eomes, GzmK, and IFN-γ, was promoted by IL-4 and IL-12-secreting myeloid dendritic cells. Consistently, Th1 effector memory cells contained precommitted Eomes+ GzmK+ T cells. Stimulation with T-cell receptor (TCR) agonists and IL-27 promoted the generation of Tr1-like effector cells by inducing switching from CD40L to IL-10. Importantly, CD4+ Eomes+ T-cell subsets were present in lymphoid and nonlymphoid tissues, and their frequencies varied systemically in patients with inflammatory bowel disease and graft-versus-host disease. We propose that Eomes+ Tr1-like cells are effector cells of a unique GzmK-expressing CD4+ T-cell subset.

Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells / P. Gruarin, S. Maglie, M. De Simone, B. Häringer, C. Vasco, V. Ranzani, R. Bosotti, J.S. Noddings, P. Larghi, F. Facciotti, M.L. Sarnicola, M. Martinovic, M. Crosti, M. Moro, R.L. Rossi, M.E. Bernardo, F. Caprioli, F. Locatelli, G. Rossetti, S. Abrignani, M. Pagani, J. Geginat. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - 49:1(2019 Jan), pp. 96-111. [10.1002/eji.201847722]

Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells

M. Martinovic;F. Caprioli;S. Abrignani;M. Pagani;J. Geginat
2019

Abstract

Whether human IL-10-producing regulatory T cells ("Tr1") represent a distinct differentiation lineage or an unstable activation stage remains a key unsolved issue. Here, we report that Eomesodermin (Eomes) acted as a lineage-defining transcription factor in human IFN-γ/IL-10 coproducing Tr1-like cells. In vivo occurring Tr1-like cells expressed Eomes, and were clearly distinct from all other CD4+ T-cell subsets, including conventional cytotoxic CD4+ T cells. They expressed Granzyme (Gzm) K, but had lost CD40L and IL-7R expression. Eomes antagonized the Th17 fate, and directly controlled IFN-γ and GzmK expression. However, Eomes binding to the IL-10 promoter was not detectable in human CD4+ T cells, presumably because critical Tbox binding sites of the mouse were not conserved. A precommitment to a Tr1-like fate, i.e. concominant induction of Eomes, GzmK, and IFN-γ, was promoted by IL-4 and IL-12-secreting myeloid dendritic cells. Consistently, Th1 effector memory cells contained precommitted Eomes+ GzmK+ T cells. Stimulation with T-cell receptor (TCR) agonists and IL-27 promoted the generation of Tr1-like effector cells by inducing switching from CD40L to IL-10. Importantly, CD4+ Eomes+ T-cell subsets were present in lymphoid and nonlymphoid tissues, and their frequencies varied systemically in patients with inflammatory bowel disease and graft-versus-host disease. We propose that Eomes+ Tr1-like cells are effector cells of a unique GzmK-expressing CD4+ T-cell subset.
English
Differentiation; EOMES; Granzyme K; Regulatory T cells; Th17
Settore BIO/11 - Biologia Molecolare
Articolo
Esperti anonimi
Pubblicazione scientifica
gen-2019
Wiley
49
1
96
111
16
Pubblicato
Periodico con rilevanza internazionale
pubmed
Aderisco
info:eu-repo/semantics/article
Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells / P. Gruarin, S. Maglie, M. De Simone, B. Häringer, C. Vasco, V. Ranzani, R. Bosotti, J.S. Noddings, P. Larghi, F. Facciotti, M.L. Sarnicola, M. Martinovic, M. Crosti, M. Moro, R.L. Rossi, M.E. Bernardo, F. Caprioli, F. Locatelli, G. Rossetti, S. Abrignani, M. Pagani, J. Geginat. - In: EUROPEAN JOURNAL OF IMMUNOLOGY. - ISSN 0014-2980. - 49:1(2019 Jan), pp. 96-111. [10.1002/eji.201847722]
open
Prodotti della ricerca::01 - Articolo su periodico
22
262
Article (author)
no
P. Gruarin, S. Maglie, M. De Simone, B. Häringer, C. Vasco, V. Ranzani, R. Bosotti, J.S. Noddings, P. Larghi, F. Facciotti, M.L. Sarnicola, M. Martino...espandi
File in questo prodotto:
File Dimensione Formato  
Eomesodermin.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/611948
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 59
  • ???jsp.display-item.citation.isi??? 55
social impact